The Roslin Institute
Roslin Logo

Menu

The First Exome Sequence Completed in Pigs

PIC, a division of Genus plc, in collaboration with Edinburgh Genomics and The Roslin Institute at the University of Edinburgh, UK, announced today that they have been the first to complete exome sequencing in pigs.

Group photo at The Roslin Institute

Exome sequencing is a cost-effective strategy to selectively sequence the most important parts of DNA and enables faster genomic progress.

The extensive results of this research, published in the journal BMC Genomics in July 2014, were generated from a targeted set of 96 pigs representing the known variation in one of PIC's leading global proprietary populations in order to capture as many mutations as possible.

Exome sequencing has been used in humans to aid in the diagnosis of Mendelian disorders (genetic disorders associated with the mutation of a single gene). PIC will use the information derived from this research, which also received funding from the Roslin Foundation and the Biotechnology and Biological Sciences Research Council (BBSRC), to achieve more accurate genomic selection in swine, including work to reduce embryonic and/or fetal death loss in pregnant pigs.

 

The development of a novel genomic platform is a significant output from the long term strategic partnership between The Roslin Institute and Genus. Within the Institute, we see many applications of this platform in biomedical research as well as more applied applications in animal breeding.

Professor David HumeDirector of The Roslin Institute and a co-author of the study

Dr. Jonathan Lightner, Genus Chief Scientific Officer, congratulated Edinburgh Genomics for a well-conducted study achieving coverage statistics similar to those seen with commercially available human exome kits.

PIC will continue to invest in and partner with leading global institutions to develop the next generation of technologies that drive faster genomic progress. We are committed to using these techniques to deliver the best products to our customers.

Dr. Jonathan LightnerGenus Chief Scientific Officer

A link to the research paper can be found at: www.biomedcentral.com/1471-2164/15/550/abstract

 

About PIC and The Roslin Institute

PIC is the international leader in the provision of continuous genetic improvement in swine breeding stock and in world-class technical support to the global pork supply chain. PIC combines quantitative analytics with leading-edge biotechnology to develop breeding stock that helps our customers maximize profitability. The company, a division of Genus plc and founded in 1962, operates in 30 countries on 6 continents. www.PIC.com

The Roslin Institute is a National Institute of Bioscience (NIB) which receives Institute Strategic Programme Grant funding from the Biotechnology and Biological Sciences Research Council (BBSRC). It is a part of the College of Medicine and Veterinary Medicine of the University of Edinburgh.

The Institute undertakes research within the framework of BBSRC Institute Strategic Programmes focussed on the health and welfare of animals, and applications of basic animal sciences in human and veterinary medicine, the livestock industry and food security.

The Roslin Institute received a total of £11.6M investment from the Biotechnology and Biological Sciences Research Council in 2012-13. www.roslin.ed.ac.uk